Biolife stock.
Dec 1, 2023 · BioLife Solutions (NASDAQ:BLFS) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the superior stock?We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership, media sentiment and community ranking.
Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...21 ก.ย. 2563 ... ... shares of BioLife common stock for 100% of the outstanding shares of SciSafe. SciSafe's shareholders are also eligible over the next four ...BOTHELL, Wash., Aug. 9, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that it has entered into a definitive agreement to acquire all remaining outstanding shares of privately held Sexton ...Water bath, 37°C CryoStor CD10 (BioLife Solutions, 210102) Scalpel Surgical forceps, scissors ... 6. Add 10uL DNAse I (50mg/mL stock) to each C tube for final 100ug/mL. 7. Add 100uL Liberase TL (stock 5mg/mL) to each tube, for final 100ug/mL 8. Macerate the tissues with gentleMACS using the program m_Spleen 04.01.Current. N/A. 1 Month Ago. N/A. 3 Months Ago. N/A. BioLife Sciences Inc. analyst estimates, including BLFE earnings per share estimates and analyst recommendations.
The estimated net worth of Roderick de Greef is at least $463,582.14 as of November 30th, 2022. Mr. de Greef owns 34,314 shares of BioLife Solutions stock worth more than $463,582 as of November 20th. This net worth estimate does not reflect any other investments that Mr. de Greef may own.WebCurrent. N/A. 1 Month Ago. N/A. 3 Months Ago. N/A. BioLife Sciences Inc. analyst estimates, including BLFE earnings per share estimates and analyst recommendations.
May 10, 2023 · BioLife Solutions Reports First Quarter 2023 Financial Results. Revenue of $37.7 million increased 4% over Q1 2022, ex-COVID growth of 16% and biopreservation media revenue growth of 28%. Q1 2023 ... See the latest BioLife Solutions Inc stock price (BLFS:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
Jan 5, 2023 · First, BioLife Solutions, Inc. stock is trading at 1.95x book value of equity, which may or may not represent a value proposition. However, it should also be noted the breakdown of its book value ... BioLife Solutions Inc stock performance at a glance. Check BioLife Solutions Inc’s past financial performance, like revenue or net income, plus the top level summary of its past …31 มี.ค. 2566 ... BioLife stock price (as of May 3, 2021). $. 35.07. Value of issued shares. $. 232,741 plus: Settlement of BioLife prepaid deposits. $. 2,152.BioLife Solutions stock quote and BLFS charts. Latest stock price today and the US's most active stock market forums.
Find the latest BioLife Sciences Inc. (BLFE) stock quote, history, news and other vital information to help you with your stock trading and investing.
BioLife Solutions is a bioproduction company that develops, manufactures, and sells biopreservation media, thawing products, and shipping containers for cell and gene …
Biolife Stock Ipo: Can You Buy Stock In This Plasma Company? It’s a captivating David vs. Goliath story, where David — at least on some fronts — appears to be winning. When a stock goes ex-dividend, the value of that stock effectively falls by the dividend amount. This means if you hold a spread bet or CFD position on a company …Biolife Solutions story: Exercise or conversion by Aby Mathew of 8854 shares of Biolife Solutions subject to Rule 16b 3 and other headlines for Biolife SolutionsBiolife Solutions story: Acquisition by Duross Amy of 14730 shares of Biolife Solutions subject to Rule 16b 3 and other headlines for Biolife SolutionsGet the latest BioLife Solutions, Inc. (BLFS) stock quote, history, news and other vital information to help you with your stock trading and investing. See the company's …BOTHELL, Wash., Nov. 9, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy (CGT) and the broader biopharma markets, today announced financial results for the three and nine months …Web
BOTHELL, Wash., Nov. 9, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy (CGT) and the broader biopharma markets, today announced financial results for the three and nine months …WebDec 4, 2023 · Rhumbline Advisers decreased its holdings in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 8.1% in the second quarter, Holdings Channel.com reports. The institutional investor owned 80,251 shares of the medical equipment provider’s stock after selling 7,097 shares during the period. Rhumbline Advisers’ holdings in BioLife Solutions were worth $1,774,000 as of its most recent […] Nov 8, 2023 · Biolife Solutions releases figures for Q3 on November 9. Wall Street analysts predict losses per share of $0.364. Go here to track Biolife Solutions stock price in real-time ahead of earnings. Conestoga Capital Advisors highlighted stocks like BioLife Solutions, Inc. (NASDAQ:BLFS) in its Q3 2022 investor letter. Headquartered in Bothell, Washington, BioLife Solutions, Inc. (NASDAQ:BLFS ...Mar 22, 2021 · BioLife will issue 6,646,870 shares of common stock for 100% of the outstanding shares of Stirling in an all-stock transaction, which is expected to close early in the second quarter of 2021. With Stirling, BioLife believes that total GAAP revenue in 2021 will exceed $100 million and the transaction is expected to be accretive on an adjusted ...
BOTHELL, Wash., Aug. 8, 2019 / PRNewswire / -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best in class bioproduction tools for cell and gene therapies, today announced that it has executed a share exchange agreement to effect the acquisition of SAVSU Technologies, a leading developer of advanced ...BioLife Solutions, Inc. (NasdaqCM:BLFS) entered into a definitive agreement and plan of merger to acquire Global Cooling, Inc. for approximately $270 million on March 19, 2021. Under the terms of the transaction, BioLife will issue 6.65 million shares of its common stock. The consideration also include the assumption of $8.7 million debt.Web
BioLife Solutions Trading Up 2.5 %. NASDAQ BLFS traded up $0.33 on Monday, hitting $13.58. 44,504 shares of the stock were exchanged, compared to its average volume of 403,529. The company’s 50 ...BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies.Chief Quality Officer Of Biolife Solutions Trades $760K In Company Stock. (Benzinga) Sep-20-21 08:00AM. BioLife Solutions Appoints Joydeep Goswami, MBA, PhD to Board of Directors. (PR Newswire) BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings ... May 10, 2023 · BioLife Solutions Reports First Quarter 2023 Financial Results. Revenue of $37.7 million increased 4% over Q1 2022, ex-COVID growth of 16% and biopreservation media revenue growth of 28%. Q1 2023 ... BioLife Sciences Inc. (OTC:BLFE) is a commercialization accelerator of innovative and disruptive technologies for the healthcare, beauty and food & beverage industry sectors. One of BioLife Science’s core building block strategies is to develop, partner and assist innovative companies with commercialization of leading-edge technologies. KNOW ...WebInvestors. Overview. Financial Highlights. Quarterly Results. Stock Information. Securities Report & Form 20-F. IR Events. We bring our values to life through actions based on Patient-Trust-Reputation-Business, in that order. We believe that if we focus first on Patients, Trust and Reputation, we know we will build a sustainable and high ...
Get the latest Biolife Sciences Inc (BLFE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Get the latest BioLife Solutions, Inc. (BLFS) stock quote, history, news and other vital information to help you with your stock trading and investing. See the company's performance outlook, earnings date, dividend and yield, fair value, ratings and more.
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy (CGT) and broader biopharma markets, today announced ...BioLife Solutions Debt Current yearly trend continues to be comparatively stable with very little volatility. Debt Current will likely drop to about 4.2 M in 2023. From the period from 2010 to 2023, BioLife Solutions Debt Current quarterly data regression had r-squared of 0.57 and coefficient of variation of 91.26.At this time, BioLife Solutions' Selling General and …Dec 1, 2023 · Dividends. A high-level overview of BioLife Solutions, Inc. (BLFS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. BIOLIFE SOLUTIONS INC NEW COM STK (DE); BioLife Solutions, Inc. BioLife Solutions, Inc. View SEC Filings ... Stock Lookup. Enter stock name: use * for wildcard.Congenital TTP is a life-threatening, rare genetic disorder with debilitating chronic symptoms. Find the latest Takeda Pharmaceutical Company Limited (TAK) stock quote, history, news and other ...In today’s fast-paced world, it can be challenging to stay organized and manage our time effectively. With so many tasks and responsibilities vying for our attention, it’s crucial to have a reliable tool that can help us stay on track. This...Chief Quality Officer Of Biolife Solutions Trades $760K In Company Stock. (Benzinga) Sep-20-21 08:00AM. BioLife Solutions Appoints Joydeep Goswami, MBA, PhD to Board of Directors. (PR Newswire) BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings ...Biolife Solutions Inc (NASDAQ:BLFS) has a beta value of 1.60 and has seen 2.24 million shares traded in the last trading session. The company, currently valued at $596.91M, closed the last trade at $13.25 per share which meant it gained $0.88 on the day or 7.11% during that session. The BLFS stock ...BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Misses Revenue Estimates Zacks - Wed May 10, 4:35PM CDT . BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of -60% and 12.89%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?The deal is an all-stock transaction that will grow BioLife Solutions revenue by 80% by the end of the year with accretive impact to bottom-line results in 2022. The upgrade comes from Benchmark and is from Neutral to Buy. The price target is $54 or 40% from upside from Monday’s close but don’t rush to buy just yet.Web
Institutional investors purchased a net $3.8 million shares of BLFS during the quarter ended June 2019. This may signal that the smart money is gaining interest ...At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to ...Oral Biolife is an innovative biotechnology company out of Temple University that utilizes the unique properties of Piezo materials to develop groundbreaking, first-to-market products. Their lead ...Conestoga Capital Advisors highlighted stocks like BioLife Solutions, Inc. (NASDAQ:BLFS) in its Q3 2022 investor letter. Headquartered in Bothell, Washington, BioLife Solutions, Inc. (NASDAQ:BLFS ...Instagram:https://instagram. rite aid stock newstellus banktriad vs 21st mortgagedollar20 stocks BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets. dow tonnyse brk.b If this sounds like the kind of workplace you would thrive in, please have a look at our current openings and apply! Perks of working at BioLife Solutions include: At-market competitive wages. Affordable, high-quality medical, dental and vision insurance for team members and their dependents. 401k matching program. Generous company stock awards. snowflake srock Operating income, quarterly and annual stats of BIOLIFE SOLUTIONS DL ... Stock Screener · Forex Screener · Crypto Pairs Screener · Crypto Coins Screener ...Nov 29, 2023 · Complete BioLife Sciences Inc. stock information by Barron's. View real-time BLFE stock price and news, along with industry-best analysis.